Eton Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-6.9M | $13.2M |
| FY2018 | — | $26.3M | $26.7M |
| FY2019 | $4.5M | $10.6M | $12.1M |
| FY2020 | $6.5M | $17.6M | $21.3M |
| FY2021 | $5.3M | $17.6M | $14.4M |
| FY2022 | $5.4M | $13.1M | $16.3M |
| FY2023 | $0 | $15.5M | $21.4M |
| FY2024 | $29.8M | $24.4M | $14.9M |
| FY2025 | $21.8M | $26.2M | $25.9M |